(Medscape) – A multidisciplinary team from China has successfully transplanted a gene-modified pig liver into a human recipient diagnosed with brain death. During a 10-day observation period, the porcine liver produced bile and porcine albumin, maintained stable blood flow, and showed no signs of rejection.

The report of the transplantation — published in the journal Nature — is the first known peer-reviewed publication describing the transplantation of a gene-modified pig liver to a human, according to a press statement. (Read More)